WP THYROID Trademark

Trademark Overview

On Tuesday, December 20, 2022, a trademark application was filed for WP THYROID with the United States Patent and Trademark Office. The USPTO has given the WP THYROID trademark a serial number of 97725693. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 8, 2025. This trademark is owned by SPUD Holdings, LLC. The WP THYROID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of thyroid disorders
wp thyroid

General Information

Serial Number97725693
Word MarkWP THYROID
Filing DateTuesday, December 20, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of thyroid disorders
NOT AVAILABLETHYROID

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSPUD Holdings, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAlpharetta, GA 30004
Party NameSPUD Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAlpharetta, GA 30004

Trademark Events

Event DateEvent Description
Friday, December 23, 2022NEW APPLICATION ENTERED
Tuesday, October 24, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 24, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 22, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, January 22, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, April 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 20, 2023ASSIGNED TO EXAMINER
Thursday, April 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 13, 2024LETTER OF SUSPENSION E-MAILED
Saturday, April 13, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 15, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 13, 2024SUSPENSION LETTER WRITTEN
Thursday, January 2, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 8, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, July 8, 2025SOU EXTENSION 1 FILED
Tuesday, July 8, 2025SOU EXTENSION 1 GRANTED
Wednesday, July 9, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

thyroid disorders treatment preparations pharmaceutical